Zentalis Pharmaceuticals Files 8-K
Ticker: ZNTL · Form: 8-K · Filed: Jun 2, 2025 · CIK: 1725160
| Field | Detail |
|---|---|
| Company | Zentalis Pharmaceuticals, Inc. (ZNTL) |
| Form Type | 8-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, disclosure
Related Tickers: ZNTL
TL;DR
ZENTALIS FILES 8-K - STANDARD REPORTING
AI Summary
Zentalis Pharmaceuticals, Inc. filed an 8-K on June 2, 2025, reporting events as of May 31, 2025. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits, with no specific material events detailed in the provided text.
Why It Matters
This filing indicates Zentalis Pharmaceuticals is providing updates and financial information to the SEC, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any immediate material changes or risks.
Key Players & Entities
- Zentalis Pharmaceuticals, Inc. (company) — Registrant
- May 31, 2025 (date) — Earliest event reported
- June 2, 2025 (date) — Filing date
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
What is the reporting date for the earliest event mentioned in the filing?
The earliest event reported is as of May 31, 2025.
When was this 8-K form filed with the SEC?
This 8-K form was filed as of date June 2, 2025.
What is the Standard Industrial Classification (SIC) code for Zentalis Pharmaceuticals, Inc.?
The SIC code for Zentalis Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What state is Zentalis Pharmaceuticals, Inc. incorporated in?
Zentalis Pharmaceuticals, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding Zentalis Pharmaceuticals, Inc. (ZNTL).